
TOKYO -- A Japanese government expert panel gave the green light to Merck's antiviral pill molnupiravir on Friday, making it the country's first oral treatment against COVID.
Treatment drug already approved in nations including U.S., U.K. and Philippines
TOKYO -- A Japanese government expert panel gave the green light to Merck's antiviral pill molnupiravir on Friday, making it the country's first oral treatment against COVID.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.